Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SERINC2///SEL1L3 |
Upstream (Parents) |
---|
(<<) GALNT7 → SERINC2///SEL1L3 |
(<<) MYC → SERINC2///SEL1L3 |
(<<) LOC151162 → SERINC2///SEL1L3 |
(<<) SLC38A1 → SERINC2///SEL1L3 |
(<<) CS → SERINC2///SEL1L3 |
Downstream (Children) |
---|
SERINC2///SEL1L3 → SFI1 (>>) |
SERINC2///SEL1L3 → LOC151162 (>>) |
SERINC2///SEL1L3 → HIST1H1C (>>) |
SERINC2///SEL1L3 → NQO2 (>>) |
SERINC2///SEL1L3 → POU5F1B (>>) |
SERINC2///SEL1L3 → MFSD10 (>>) |
SERINC2///SEL1L3 → HIST2H2AA4///HIST2H2AA3 (>>) |